Dynavax Technologies Corp (NASDAQ:DVAX)

23.57
Delayed Data
As of Jul 02
 +0.33 / +1.42%
Today’s Change
13.10
Today|||52-Week Range
26.89
+39.80%
Year-to-Date
No recent news for Dynavax Technologies Corp.

Today’s Trading

Previous close23.24
Today’s open23.31
Day’s range22.86 - 23.64
Volume319,924
Average volume (3 months)379,284
Market cap$686.4M
Dividend yield--
Data as of 3:59pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)+9.21%
Earnings growth (this year)-10.69%
Earnings growth (next 5 years)--
Revenue growth (last year)-1.95%
P/E ratioNM
Price/Sales40.18
Price/Book6.13

Competitors

 Today’s
change
Today’s
% change
OMEROmeros Corp+0.12+0.71%
OMEDOncoMed Pharmaceutic...-0.43-1.98%
CORTCorcept Therapeutics...0.000.00%
TKMRTekmira Pharmaceutic...-0.08-0.68%
Data as of 3:59pm ET, 07/02/2015

Financials

Next reporting dateJuly 22, 2015
EPS forecast (this quarter)-$0.98
Annual revenue (last year)$11.0M
Annual profit (last year)-$90.7M
Net profit margin-822.35%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
Eddie J. Gray
Senior Vice President-Operations &
Quality
David F. Novack
Corporate headquarters
Berkeley, California

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers